KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma

• Ozlen Saglam,

  Roles Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Department of Surgical Pathology, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Zhenya Tang,

  Roles Writing – review & editing

  Affiliation Department of Hematopathology, Section of Clinical Cytogenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Guilin Tang,

  Roles Writing – review & editing

  Affiliation Department of Hematopathology, Section of Clinical Cytogenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• L. Jeffrey Medeiros,

  Roles Writing – review & editing

  Affiliation Department of Hematopathology, Section of Clinical Cytogenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Gokce A. Toruner

  Roles Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: gatoruner@mdanderson.org

  Affiliation Department of Hematopathology, Section of Clinical Cytogenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  http://orcid.org/0000-0002-5305-6337

  ⨯